NEW YORK (GenomeWeb) – Two independent research teams have found clues that circulating tumor DNA (ctDNA) can offer clinically useful insights into colorectal cancers (CRC) that have not progressed to metastasis.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.